Clinical trials for Acute monoblastic/monocytic leukemia
8 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 2NCT07512700Venetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic LeukemiaChinese PLA General Hospital · PI: Liping Dou, Doctor
- RECRUITINGPhase 2NCT06504459Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AMLOHSU Knight Cancer Institute · PI: Curtis A Lachowiez
- RECRUITINGPhase 1NCT06429449Mitoxantrone for Venetoclax Resistant Acute Myeloid LeukemiaUniversity of Colorado, Denver · PI: Andrew Kent, MD, PhD
- ACTIVE NOT RECRUITINGN/ANCT05871008Integrated Actionable Aging Assessment for Cancer Patients PilotUniversity of Colorado, Denver · PI: Russell E Glasgow
- RECRUITINGPhase 2NCT05566054Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic LeukemiaThe First Affiliated Hospital of Soochow University
- RECRUITINGPhase 2NCT04282187Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative NeoplasmsUniversity of Washington · PI: Anna Halpern
- ACTIVE NOT RECRUITINGPhase 2NCT04195945CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit PatientsFred Hutchinson Cancer Center · PI: Roland Walter
- RECRUITINGPhase 2NCT03737955Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid LeukemiaUniversity of Washington · PI: Mary-Elizabeth Percival